1,1-Bis(3′-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells

Molecular Carcinogenesis

Volumn 47, Issue 4, 2008, Pages 252-263

  Cho, Sung Dae ^a,b   Lei, Ping ^a   Abdelrahim, Maen ^a   Yoon, Kyungsil ^a   Liu, Shengxi ^a   Guo, Jingjing ^a   Papineni, Sabitha ^a   Chintharlapalli, Sudhakar ^a   Safe, Stephen ^a,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Chonbuk National University   (South Korea)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Apoptosis; C DIMs; Colon cancer; JNK; NAG 1

Indexed keywords

1,1 BIS(3' INDOLYL) 1 (4 METHOXYPHENYL)METHANE; ANTINEOPLASTIC AGENT; APELIN RECEPTOR; DEATH RECEPTOR 5; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEAR RECEPTOR NUR77; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; 1,1 BIS(3' INDOLYL)METHANE; 1,1-BIS(3'-INDOLYL)METHANE; CELL RECEPTOR; DNA BINDING PROTEIN; GROWTH INHIBITOR; INDOLE DERIVATIVE; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; COLON CANCER; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MOUSE; NAG1 GENE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS MUSCULUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HUMANS; INDOLES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 41449083708     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20378     Document Type: Article

References (49)

1. Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1988;1:183-188.
2. Ryseck RP, Macdonald-Bravo H, Mattei MG, Ruppert S, Bravo R. Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J 1989;8:3327-3335.
3. Scearce LM, Laz TM, Hazel TG, Lau LF, Taub R. RNR-1, a nuclear receptor in the NGFI-B/Nur77 family that is rapidly induced in regenerating liver. J Biol Chem 1993;268:8855-8861.
4. Maruyama K, Tsukada T, Bandoh S, et al. Expression of the putative transcription factor NOR-1 in the nervous, the endocrine and the immune systems and the developing brain of the rat. Neuroendocrinology 1997;65:2-8.
5. Bandoh S, Tsukada T, Maruyama K, Ohkura N, Yamaguchi K. Differential expression of NGFI-B and RNR-1 genes in various tissues and developing brain of the rat: Comparative study by quantitative reverse transcription-polymerase chain reaction. J Neuroendocrinol 1997;9:3-8.
6. DeYoung RA, Baker JC, Cado D, Winoto A. The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. J Biol Chem 2003;278:47104-47109.
7. Zetterstrom RH, Solomin L, Jansson L, et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997;276:248-250.
8. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 1998;95:4013-4018.
9. Lee SL, Wesselschmidt RL, Linette GP, et al. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995;269:532-535.
10. Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors: Shifting endocrinology into reverse. Science 1999;284:757-760.
11. He YW. Orphan nuclear receptors in T lymphocyte development. J Leukoc Biol 2002;72:440-446.
12. Zhang Y, Dufau ML. Gene silencing by nuclear orphan receptors. Vitam Horm 2004;68:1-48.
13. Ordentlich P, Yan Y, Zhou S, Heyman RA. Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurrl. J Biol Chem 2003;278:24791-24799.
14. Wansa KD, Harris JM, Yan G, Ordentlich P, Muscat GE. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J Biol Chem 2003;278:24776-24790.
15. Chintharlapalli S, Burghardt R, Papineni S, et al. Activation of Nur77 by selected 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J Biol Chem 2005;280:24903-24914.
16. Cho SD, Yoon K, Chintharlapalli S, et al. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and independent pathways. Cancer Res 2007;67:674-683.
17. Li H, Kolluri SK, Gu J, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000;289:1159-1164.
18. Lin B, Kolluri SK, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004;116:527-540.
19. Wu Q, Liu S, Ye XF, Huang ZW, Su WJ. Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis 2002;23:1583-1592.
20. Holmes WF, Soprano DR, Soprano KJ. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. J Cell Biochem 2003;89:262-278.
21. Holmes WF, Soprano DR, Soprano KJ. Early events in the induction of apoptosis in ovarian carcinoma cells by C D437:activation of the p38 MAP kinase signal pathway. Oncogene 2003;22:6377-6386.
22. Wilson AJ, Arango D, Mariadason JM, Heerdt BG, Augenlicht LH. TR3/Nur77 in colon cancer cell apoptosis. Cancer Res 2003;63:5401-5407.
23. Hong J, Samudio I, Liu S, Abdelrahim M, Safe S. Peroxisome proliferator-activated receptor γ-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology 2004;145:5774-5785.
24. Chintharlapalli S, Papineni S, Baek SJ, Liu S, Safe S. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and NAG-1. Mol Pharmacol 2005;68:1782-1792.
25. Kassouf W, Chintharlapalli S, Abdelrahim M, et al. Inhibition of bladder tumor growth by 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes: A new class of peroxisome proliferator-activated receptor γ agonists. Cancer Res 2006;66:412-418.
26. Chintharlapalli S, Papineni S, Safe S. 1,1-Bis(3′-indolyl)-1-(p- substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARγ-dependent and PPARγ-independent pathways. Mol Cancer Ther 2006;5:1362-1370.
27. Lei P, Abdelrahim M, Safe S. 1,1-Bis(3′-indolyl)-1-(p- substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways. Mol Cancer Ther 2006;5:2324-2336.
28. Chintharlapalli S, Papineni S, Safe SH. 1,1-Bis(3′-indolyl)-1- (p-substituted phenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through PPARγ-independent pathways. Mol Pharmacol 2007;71:558-569.
29. Contractor R, Samudio I, Estrov Z, et al. A novel ring-substituted diindolylmethane 1,1-bis[3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane inhibits ERK activation and induces apoptosis in acute myeloid leukemia. Cancer Res 2005;65:2890-2898.
30. Qin C, Morrow D, Stewart J, et al. A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes. Mol Cancer Therap 2004;3:247-259.
31. Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S. 3,3′-Diindolylmethane (DIM) and derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006;27:717-728.
32. Chintharlapalli S, Smith R III, Samudio I, Zhang W, Safe S. 1,1-Bis(3′-indoiyl)-1-(p-substituted phenyl)methanes induce peroxisome proliferator-activated receptor γ-mediated growth inhibition, transactivation and differentiation markers in colon cancer cells. Cancer Res 2004;64:5994-6001.
33. Tan M, Wang Y, Guan K, Sun Y. PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc Natl Acad Sci USA 2000;97:109-114.
34. Li PX, Wong J, Ayed A, et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000;275:20127-20135.
35. Baek SJ, Horowitz JM, Eling TE. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 2001;276:33384-33392.
36. Shertzer HG, Senft AP. The micronutrient indole-3-carbinol: Implications for disease and chemoprevention. Drug Metabol Drug Interact 2000;17:159-188.
37. Preobrazhenskaya MN, Bukhman VM, Korolev AM, Efimov SA. Ascorbigen and other indole-derived compounds from Brassica vegetables and their analogs as anticarcinogenic and immunomodulating agents. Pharmacol Therap 1993;60:301-313.
38. Murillo G, Mehta RG. Cruciferous vegetables and cancer prevention. Nutr Cancer 2001;41:17-28.
39. Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway. Br J Cancer 2004;91:1358-1363.
40. Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-κB contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 2005;65:364-371.
41. Hong C, Firestone GL, Bjeldanes LF. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 2002;63:1085-1097.
42. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003;41:745-752.
43. Sun S, Han J, Ralph WM, Jr., et al. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 2004;9:76-87.
44. Le HT, Schaldach CM, Firestone GL. Bjeldanes LF. Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 2003;278:21136-21145.
45. Hong C, Kim HA, Firestone GL, Bjeldanes LF. 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002;23:1297-1305.
46. Cover CM, Hsieh SJ, Tran SH, et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998;273:3838-3847.
47. Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ. Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 2005;328:63-69.
48. Chen I, McDougal A, Wang F, Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 1998;19:1631-1639.
49. Vanderlaag K, Samudio I, Burghardt R, Barhoumi R, Safe S. Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3′- indolyl)methane (DIM) and 5,5′-dibromoDIM. Cancer Lett 2006;236:198-212.